Christopher James Arthur Duncan

机构：Royal Victoria Infirmary, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle University · ORCID：0000-0003-4181-2315

发表论文 438 篇 · 总被引 27575 次 · h-index 63

代表论文

• SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway (2022 · Nature Microbiology · 被引 739)
• Efficacy and Safety of an mRNA-Based RSV PreF Vaccine in Older Adults (2023 · New England Journal of Medicine · 被引 503)
• SARS-CoV-2-specific immune responses and clinical outcomes after COVID-19 vaccination in patients with immune-suppressive disease (2023 · Nature Medicine · 被引 137)
• Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial (2023 · The Lancet · 被引 134)
• Human leukocyte antigen alleles associate with COVID-19 vaccine immunogenicity and risk of breakthrough infection (2022 · Nature Medicine · 被引 98)
• Efficacy, safety, and immunogenicity of a booster regimen of Ad26.COV2.S vaccine against COVID-19 (ENSEMBLE2): results of a randomised, double-blind, placebo-controlled, phase 3 trial (2022 · The Lancet Infectious Diseases · 被引 90)